Patents by Inventor John F Parkinson

John F Parkinson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Lipoxin Aanalogs
    Patent number: 7223798
    Abstract: This invention is directed to lipoxin A4 analogs of the following formula (II): wherein R1, R2, R3, R4 and R5 are described herein. These analogs are useful in treating inflammatory and autoimmune disorders in humans. These analogs are also useful in treating pulmonary or respiratory tract inflammation in humans.
    Type: Grant
    Filed: February 18, 2004
    Date of Patent: May 29, 2007
    Assignee: Schering Aktiengesellschaft
    Inventors: John G Bauman, William J Guilford, John F Parkinson, Werner Skuballa, Babu Subramanyam
  • Lipoxin A4 analogs
    Patent number: 6831186
    Abstract: This invention is directed to lipoxin A4 analogs of the following formula (I) and (II): wherein R1, R2, R3, R4 and R5 are described herein. These analogs are useful in treating inflammatory and autoimmune disorders in humans. These analogs are also useful in treating pulmonary or respiratory tract inflammation in humans.
    Type: Grant
    Filed: October 22, 2002
    Date of Patent: December 14, 2004
    Assignee: Schering Aktiengesellschft
    Inventors: John G Bauman, William J Guilford, John F Parkinson, Werner Skuballa, Babu Subramanyam
  • Lipoxin A4 analogs
    Publication number: 20040162433
    Abstract: This invention is directed to lipoxin A4 analogs of the following formula (I) and (II): 1
    Type: Application
    Filed: February 18, 2004
    Publication date: August 19, 2004
    Applicant: Schering Aktiengesellschaft
    Inventors: John G. Bauman, William J. Guilford, John F. Parkinson, Werner Skuballa, Babu Subramanyam
  • eNOS mutants useful for gene therapy
    Publication number: 20040096881
    Abstract: The present invention provides endothelial nitric oxide synthase (eNOS) polypeptide mutants, and polynucleotides encoding such polypeptide mutants, useful for gene therapy. In particular, the invention provides eNOS polypeptide mutants having one or more mutations in an amino acid sequence corresponding to a functional domain of a mammalian eNOS. More particularly, the invention provides eNOS polypeptide mutants having at least one mutation at a position corresponding to an amino acid residue in a calmodulin-binding site that is phosphorylated in mammalian cells, where the mutation is not an amino acid substitution to Ala or Asp in an eNOS polypeptide mutant having a single mutation that is at the phosphorylation site; and to polynucleotides encoding such polypeptide mutants. The present invention further provides prophylactic, diagnostic, and therapeutic methods of using such eNOS polypeptide mutants and polynucleotides.
    Type: Application
    Filed: August 15, 2003
    Publication date: May 20, 2004
    Applicant: Schering Aktiengesellschaft
    Inventors: Eric Blasko, Katalin Kauser, John F. Parkinson
  • Lipoxin A4 analogs
    Publication number: 20030139376
    Abstract: This invention is directed to lipoxin A4 analogs of the following formula (I) and (II): 1
    Type: Application
    Filed: October 22, 2002
    Publication date: July 24, 2003
    Applicant: Schering Aktiengesellschaft
    Inventors: John G. Bauman, William J. Guilford, John F. Parkinson, Werner Skuballa, Babu Subramanyam